888集团(中国)电子游戏有限公司
About us
Our Values
Development Milestone
Products
Product List for API
Recommended API
Product list for Chemicals and Intermediates
Product list for Chemicals and Intermediates
News
Contract Manufacturing
API and Pharmaceutical Intermediates
OTC and Generics
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Contact Us
中文版
旧版入口
About us
News
Investor Relation
Products
Contract Manufacturing
Contact Us
Investor Relation
Investor Relation
PERIODIC REPORT
INTERIM REPORT
INVESTORS SERVICE
Overseas regulatory announcement-Announcement on Febuxostat Obtaining Notificat
2023-10-10
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-10-09
Overseas Regulatory Announcement-Announcement on Drugs of Wholly-owned Subsidiar
2023-09-20
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-09-01
Announcement Notice of Board Meeting
2023-08-14
Overseas Regulatory Announcement-Announcement on Alogliptin Benzoate Tablets Obt
2023-08-11
Supplemental Announcement In Relation To Annual Report For The Year Ended 31 Dec
2023-08-07
Monthly Return of Equity Issuer on Movements in Securities for the month ended 3
2023-08-01
List of Directors And Their Roles And Functions
2023-07-26
Resignation of Independent Non-executive Director and Ceased to Act as Members o
2023-07-26
<
...
6
7
8
9
10
11
12
...
>